Beyond Air™ Scheduled to Announce Fiscal Year 2020 Financial Results on Monday, June 22nd
June 8, 2020
Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit™ in COVID-19 Patients
May 26, 2020
Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study
May 20, 2020
Beyond Air™ to Present New Data in an e-Poster Presentation at the Upcoming AACR Virtual Annual Meeting II on June 22nd to 24th
May 15, 2020
Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital
May 15, 2020
Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States
April 16, 2020
Beyond Air Accelerates LungFit™ BRO COVID-19 Program
March 18, 2020
Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients
March 16, 2020
Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET
March 5, 2020
Beyond Air Hosting Analyst Day on March 5, 2020
February 25, 2020

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe